Receptor binding domain of SARS‐CoV‐2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2
Background: COVID-19 is an infectious disease declared as a global pandemic caused by SARS-CoV-2 virus. Genomic changes in the receptor binding domain (RBD) region of SARS‐CoV‐2 led to an increased, infectivity in humans through interaction with the angiotensin-converting enzyme2 (ACE2) receptor. Si...
Saved in:
Main Authors: | Shankargouda Patil (Author), Khalid J. Alzahrani (Author), Hamsa Jameel Banjer (Author), Ibrahim Faisal Halawani (Author), Hosam Alzahrani (Author), Malik A. Altayar (Author), Sarah Albogami (Author), Robert Fua Angeles (Author), Ali Abdel-Halim (Author), Shilpa Bhandi (Author), A. Thirumal Raj (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multi-target potential of Indian phytochemicals against SARS-CoV-2: A docking, molecular dynamics and MM-GBSA approach extended to Omicron B.1.1.529.
by: Jency Roshni, et al.
Published: (2022) -
A Mini Review on SARS-COVID-19-2 Omicron Variant (B.1.1.529)
by: Santhosh Kumar Ettaboina, et al.
Published: (2021) -
The updated strategy to overcome new challenge: Omicron variant (B.1.1.529) pandemic
by: HyokJu Ri, et al.
Published: (2022) -
Characteristics of the SARS-CoV-2 Omicron (B.1.1.529) Variant and Emerging Impact on Global Public Health
by: Md. Rabiul Islam, et al.
Published: (2022) -
Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
by: Chiranjib Chakraborty, et al.
Published: (2023)